SEC 13F Intelligence

Elk Creek Partners, LLC / HALO

Elk Creek Partners, LLC’s Halozyme Therapeutics Inc Position

Does Elk Creek Partners, LLC own Halozyme Therapeutics Inc (HALO)? Yes — 654.4K shares worth $12M (+2.02% of its 13F portfolio) as of Q1 2020, up from 638.9K shares the prior filed quarter.

Position Value
$12M
Q1 2020
Shares
654.4K
% of Portfolio
+2.02%
Quarters Held
6
currently held

Position History HALO

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $13MQ1 ’19Q2 ’19: $14MQ2 ’19Q3 ’19: $12MQ3 ’19Q4 ’19: $11MQ4 ’19Q1 ’20: $12MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020654.4K$12M+2.02%
Q4 2019638.9K$11M+1.30%
Q3 2019758.6K$12M+1.01%
Q2 2019810.0K$14M+1.04%
Q1 2019788.7K$13M+0.92%
Q4 2018740.8K$11M+0.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Elk Creek Partners, LLC’s full portfolio or all institutional holders of HALO.